BIO Submits Comments to EPA on the Renewable Fuel Standards for 2018 and Biomass-Based Diesel Volume for 2019
August 31, 2017
BIO submitted comments on the U.S. Environmental Protection Agency (EPA) proposed rule, Renewable Fuel Standard Program: Standards for 2018 and Biomass-Based Diesel Volume for 2019.
In the comments, BIO explains advanced and cellulosic biofuels are poised for rapid growth in 2018 – if the final 2018 RFS rule allows producers to access the transportation fuel market. To grow the U.S. biofuels industry and jobs in rural America, the 2018 RFS should not arbitrarily limit growth of advanced and cellulosic biofuels.
BIO asks EPA to reject the new methodology of forecasting gallons under the cellulosic waiver and return to a forward-looking forecasting methodology that considers current market activity. BIO also asks EPA to expedite pathway approvals and adjust its treatment of carryover RINs.
Download Full Comments Below
BIO Comments - Docket ID No. EPA-HQ-OA-2017-0091- 2018 RFS RVO
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
BIO submitted comments on the U.S. Environmental Protection Agency (EPA) proposed rule, Renewable Fuel Standard Program: Standards for 2018 and Biomass-Based Diesel Volume for 2019.
In the comments, BIO explains advanced and cellulosic biofuels are poised for rapid growth in 2018 – if the final 2018 RFS rule allows producers to access the transportation fuel market. To grow the U.S. biofuels industry and jobs in rural America, the 2018 RFS should not arbitrarily limit growth of advanced and cellulosic biofuels.
BIO asks EPA to reject the new methodology of forecasting gallons under the cellulosic waiver and return to a forward-looking forecasting methodology that considers current market activity. BIO also asks EPA to expedite pathway approvals and adjust its treatment of carryover RINs.